Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

AbbVie to Pay $595 Million for Boehringer Immunology Treatments
Bloomberg
Mon, 03/7/16 - 09:33 am
Tags:
AbbVie, Boehringer Ingelheim, M&A, psoriasis, Crohn’s disease, asthma
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Fierce Pharma Marketing
Wed, 02/3/16 - 05:30 pm
Tags:
bloodthinners, Bristol-Myers Squibb, Eliquis, Xarelto, Pradaxa, Bayer, Pfizer, JNJ, Boehringer Ingelheim
Lilly, BI step closer to a new heart-risk marketing push on Jardiance
Fierce Pharma Marketing
Wed, 01/27/16 - 04:12 pm
Tags:
Eli Lilly, Boehringer Ingelheim, diabetes, Jardiance, SGLT2 inhibitor
11 biopharma execs & experts look back on 2015: A record year for record-breaking
BioPharma Dive
Wed, 12/23/15 - 09:32 pm
Tags:
Sanofi, Pfenex, inVentiv, Novocure, Accenture, Boehringer Ingelheim
Boehringer Ingelheim will hire 400, invest €500M in Vienna biologics operation
Fierce Pharma
Wed, 12/23/15 - 09:29 pm
Tags:
Boehringer Ingelheim, drug manufacturing, Austria
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Tags:
Boehringer Ingelheim, breakthrough therapies, BI1482694, AstraZeneca, Clovis Oncology, non-small cell lung cancer
FDA approves cheaper version of top-selling diabetes drug
Yahoo/Reuters
Wed, 12/16/15 - 07:56 pm
Tags:
FDA, diabetes, insulin, Lantus, Eli Lilly, Boehringer Ingelheim, Sanofi
Sanofi plans to reshape via $20 bln asset swap with Boehringer
Yahoo/Reuters
Tue, 12/15/15 - 09:58 am
Tags:
Sanofi, Boehringer Ingelheim
Boehringer slashes its R&D budget with a new focus on collaboration
Fierce Biotech
Wed, 11/11/15 - 09:15 pm
Tags:
Boehringer Ingelheim, R&D
Victoza Brings About No Effects To Help Control Heart Failure
Bidness, ETC
Tue, 11/10/15 - 03:54 pm
Tags:
diabetes, heart failure, Jardiance, Victoza, Novo Nordisk, Eli Lilly, Boehringer Ingelheim
Lilly diabetes drug cuts heart failure death, hospitalization -study
Yahoo/Reuters
Mon, 11/9/15 - 03:33 pm
Tags:
Eli Lilly, Jardiance, diabetes, heart failure, Boehringer Ingelheim
Boehringer Ingelheim picks family member to lead it through tough times
Fierce Pharma
Fri, 11/6/15 - 03:32 pm
Tags:
Boehringer Ingelheim
Boehringer expands its crowdsourced research to include psychiatric R&D
Fierce Biotech
Mon, 11/2/15 - 06:11 pm
Tags:
Boehringer Ingelheim, R&D, crowdsourcing
Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Fierce Biotech
Sat, 10/17/15 - 03:30 pm
Tags:
Boehringer Ingelheim, FDA, Pradaxa, bloodthinners, Praxbind
FDA's review of BI's Pradaxa was 'lax' and 'permissive,' watchdog claims
Fierce Pharma
Thu, 10/15/15 - 03:54 pm
Tags:
FDA, Boehringer Ingelheim, Pradaxa
Boehringer's psoriasis drug beats Stelara in head-to-head Phase II
Fierce Biotech
Fri, 10/9/15 - 10:36 am
Tags:
Boehringer Ingelheim, JNJ, Stelara, psoriasis, BI 655066
Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance
Fierce Pharma
Mon, 10/5/15 - 05:52 pm
Tags:
payer negotiation, Jardiance, diabetes, Eli Lilly, Boehringer Ingelheim
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
Fierce Pharma
Thu, 10/1/15 - 05:29 pm
Tags:
Pradaxa, Xarelto, Eliquis, bloodthinners, Warfarin, drug safety, JNJ, Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb
Boehringer finalizes team for crowdsourced COPD R&D initiative
Fierce Biotech
Thu, 09/24/15 - 07:14 pm
Tags:
Boehringer Ingelheim, COPD, R&D, crowdsourcing, BioMed X, epigenetics
Eli Lilly Officially Puts Merck on Notice
Motley Fool
Tue, 09/22/15 - 09:50 am
Tags:
Eli Lilly, Merck, Jardiance, diabetes, Boehringer Ingelheim, Januvia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.